Malaysian Kids' nose bacteria under microscope after vaccine rollout
NCT ID NCT07545876
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how common pneumococcal bacteria are in the noses of healthy or mildly sick children under 5 in Malaysia, after the introduction of vaccines. Researchers will collect a quick nose swab from 600 children and ask parents about vaccination history. The goal is to understand which bacteria types are circulating and whether they resist antibiotics, helping guide future vaccine and treatment strategies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 600 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All children meeting the inclusion criteria, attending GP clinics, the outpatient department or admitted as hospital inpatients in sentinel teaching hospital sites. Male and female patients from the three major ethnic groups (Malay, Chinese, and Indian) will be recruited from each sentinel site.
- Ages
-
0 to 5 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged ≤5 years (0-60 months) * Hemodynamically stable at the time of sampling * Parent/guardian provides written informed consent * Resident in Malaysia for at least 3 months prior to enrolment Exclusion Criteria: * Current or recent antibiotic use within the last 30 days * Known to have an immunodeficiency or currently on chemotherapy, or post-transplant recipients or on high-dose steroids (defined as \>20mg/day or 2mg/kg/day of Prednisolone for 2 weeks or more) * Has nasal surgery * Refusal of consent by parent or guardian
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Nasopharyngeal carriage of streptococcus pneumoniae are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Avisena Women's & Children Specialist Hospital
RECRUITINGShah Alam, Selangor, 40000, Malaysia
-
CMH Specialist Hospital
RECRUITINGSeremban, Negeri Sembilan, 70200, Malaysia
-
Hospital Tuanku Jaafar
RECRUITINGSeremban, Negeri Sembilan, 70300, Malaysia
-
KMI Taman Desa Medical Centre
RECRUITINGKuala Lumpur, Kuala Lumpur, 58100, Malaysia